Quick Takeaways
- Laurence W. Lytton filed SCHEDULE 13G/A for Evoke Pharma Inc Common Stock, par value $0.0001 (EVOK).
- Disclosed ownership: 3.9%.
- Date of event: 31 Mar 2025.
Laurence W. Lytton - 31 Mar 2025 SCHEDULE 13G/A Report for Evoke Pharma Inc Common Stock, par value $0.0001 (EVOK)
- Filing Manager
- Laurence W. Lytton
- Reporting Manager
- Lytton, Laurence W.
- Symbol
- EVOK
- Shares outstanding
- 1,571,128 shares
- Disclosed Ownership
- 61,274 shares
- Ownership
- 3.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 15:51:53 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Laurence W. Lytton disclosed 3.9% ownership in Evoke Pharma Inc Common Stock, par value $0.0001 (EVOK) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 15:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lytton, Laurence W. | 3.9% | 61,274 | 61,274 | 0 | /s/ Laurence W. Lytton | Reporting person |